ophthalmology

Digital health round-up: Diagnosis by chatbot, mental health app for kids, and more

https://pharmaphorum.com/views-and-analysis/digital-health-round-up-diagnosis-by-chatbot-mental-health-app-for-kids-and-more/

New tech allows mobile-based eye tests

https://pharmaphorum.com/news/new-tech-allows-mobile-based-eye-tests/

Novartis/Spark’s sight gene therapy approved in EU

https://pharmaphorum.com/news/novartis-sparks-sight-gene-therapy-approved-in-eu/

Alcon to build digital platform to improve cataract surgery

https://pharmaphorum.com/news/alcon-to-build-digital-platform-to-improve-cataract-surgery/

Novartis challenges court ruling allowing use of Avastin in wet AMD

https://pharmaphorum.com/news/novartis-challenges-court-ruling-allowing-use-of-avastin-in-wet-amd/

Ionis and Roche to develop RNAi AMD drug in $760m deal

https://pharmaphorum.com/news/ionis-and-roche-to-develop-rnai-amd-drug-in-760m-deal/

Novartis, Bayer consider appeal as court says Avastin can be used in AMD

https://pharmaphorum.com/news/novartis-bayer-consider-appeal-as-court-says-avastin-can-be-used-in-amd/

Spark/Novartis eye gene therapy nears EU market – but at what price?

https://pharmaphorum.com/news/spark-novartis-eye-gene-therapy-luxturna/

Queen’s University Belfast and Santen to Present Opening Keynote this November

https://pharmaphorum.com/partner-content/queens-university-belfast-and-santen-to-present-opening-keynote-this-november/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search